Healthcare Industry News: collagen
News Release - December 30, 2008
Salient Surgical Technologies, Inc. Completes Move to New Corporate Headquarters
New Construction Includes Training, Manufacturing FacilitiesPORTSMOUTH, NH--(Healthcare Sales & Marketing Network)--Dec 30, 2008 -- Salient Surgical Technologies, Inc., a privately held medical technology company that develops and markets advanced energy devices for use in surgical procedures, today announced the completion of its new corporate headquarters in Portsmouth, New Hampshire at the Pease International Tradeport. The 56,658 square foot facility was built to suit by Two International Group.
"This new facility provides exciting opportunities for our continued growth," stated Joseph F. Army, Salient's President & CEO. "It brings many new capabilities to our corporate office, including a specially equipped training facility and a pilot line to support our increased investments in new product development."
About Salient Surgical
Salient Surgical Technologies, Inc. is a medical technology company that develops and markets advanced energy devices for use in surgical procedures. Salient's proprietary Transcollation(TM) technology allows surgeons to provide optimized tissue treatment at the surgical site by transforming specific types of collagen-based structures to improve patient outcomes. Salient's products are currently used in orthopedic reconstruction, spine and surgical oncology. To date, Transcollation(TM) technology has been used in over 200,000 surgical procedures.
For more information about Salient Surgical Technologies, visit the company website at www.salientsurgical.com.
Source: Salient Surgical Technologies
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!